Key Takeaways:
A law firm is investigating Empro Group Inc. (NASDAQ: EMPG) for potential securities fraud, weeks after the stock was halted by US regulators for suspected market manipulation that saw its price surge over 300%.
"The investigation concerns whether Empro and certain officers and/or directors have engaged in securities fraud or other unlawful business practices," Wolf Haldenstein Adler Freeman & Herz LLP said in a statement released May 12. The firm is soliciting shareholders who suffered losses.
Empro Group went public on July 3, 2025, selling 1.375 million shares at $4.00 each. The stock reached a high of $17.36 per share on October 6, 2025, the day it was halted from trading by the Securities and Exchange Commission. The SEC cited potential manipulation through social media recommendations as the reason for the halt.
Following the end of the SEC's suspension, NASDAQ initiated its own halt pending a request for more information, which is still in effect. The investigation by Wolf Haldenstein adds another layer of legal and financial risk for the Malaysia-based beauty and medical products company, potentially leading to a class-action lawsuit.
Empro Group operates as a holding company for subsidiaries that provide skincare, cosmetics, and medical products, including face masks and nitrile gloves, primarily serving customers in Malaysia.
The investigation seeks to represent shareholders who purchased the stock and incurred losses from the trading halt. The outcome of the probe and NASDAQ's information request will be the next key events for investors to watch.
This article is for informational purposes only and does not constitute investment advice.
